Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DNM1 | Q05193 | 2/20 | 0.47 |
| ▸ | KCNH2 | Q12809 | 6/20 | 0.35 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.33 |
| ▸ | CA2 | P00918 | 2/20 | 0.33 |
| ▸ | RECQL | P46063 | 2/20 | 0.32 |
| ▸ | HPGD | P15428 | 2/20 | 0.32 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
| ▸ | GLA | P06280 | 1/20 | 0.32 |
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.32 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.32 |
| ▸ | BLM | P54132 | 1/20 | 0.32 |
| ▸ | FAAH | O00519 | 2/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | HTT | P42858 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1858853 | 0.95 | DNM1 (0.38) | DNM1KCNH2HPGDLMNAHTT | |
| SCHEMBL358748 | 0.87 | DNM1 (0.50) | DNM1KCNH2EPHX1CA2RECQL | |
| Trifluoromethanesulfonic Acid SCHEMBL3770724 | 0.83 | DNM1 (0.58) | DNM1KCNH2EPHX1CA2RECQL | |
| Trifluoromethanesulfonic Acid SCHEMBL3645807 | 0.83 | DNM1 (0.58) | DNM1KCNH2EPHX1CA2RECQL | |
| Trifluoromethanesulfonic Acid SCHEMBL514369 | 0.83 | DNM1 (0.58) | DNM1KCNH2EPHX1CA2RECQL | |
| Trifluoromethanesulfonic Acid SCHEMBL3780709 | 0.83 | DNM1 (0.58) | DNM1KCNH2EPHX1CA2RECQL | |
| Trifluoromethanesulfonic Acid SCHEMBL28573162 | 0.83 | DNM1 (0.58) | DNM1KCNH2EPHX1CA2RECQL | |
| Trifluoromethanesulfonic Acid SCHEMBL2761030 | 0.81 | DNM1 (0.54) | DNM1KCNH2EPHX1RECQLHPGD | |
| Trifluoromethanesulfonic Acid SCHEMBL28987659 | 0.81 | DNM1 (0.54) | DNM1KCNH2EPHX1RECQLHPGD | |
| Trifluoromethanesulfonic Acid SCHEMBL2865203 | 0.81 | DNM1 (0.54) | DNM1KCNH2EPHX1RECQLHPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 99 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8568608-B2 | Vapor compression cycle utilizing ionic liquid as compressor lubricant | E I DU PONT DE NEMOURS AND COMPANY (US) | 2013-10-29 | — | — | US | claimed |
| EP-2021276-B1 | PROCESS FOR PURIFYING PERFLUORINATED PRODUCTS | DU PONT (US) | 2013-07-17 | — | — | EP | claimed |
| EP-2414476-A1 | IONIC COMPOUNDS IN LITHIUM BROMIDE/WATER ABSORPTION CYCLE SYSTEMS | E. I. du Pont de Nemours and Company (US) | 2012-02-08 | — | — | EP | claimed |
| US-20120011886-A1 | IONIC COMPOUNDS IN LITHIUM BROMIDE/WATER ABSORPTION CYCLE SYSTEMS | E. I. DU PONT DE NEMOURS AND COMPANY | 2012-01-19 | — | — | US | claimed |
| US-20110195212-A1 | Flame Retardant Polycarbonate Compositions | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 2011-08-11 | — | — | US | claimed |
| US-7829739-B2 | Ionic liquids | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 2010-11-09 | — | — | US | claimed |
| WO-2010117836-A1 | IONIC COMPOUNDS IN LITHIUM BROMIDE/WATER ABSORPTION CYCLE SYSTEMS | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2010-10-14 | — | — | WO | claimed |
| US-20100204521-A1 | PROCESSES FOR MAKING DIBUTYL ETHERS FROM 2-BUTANOL | E. I. DU PONT DE NEMOURS AND COMPANY | 2010-08-12 | — | — | US | claimed |
| US-20100197974-A1 | PROCESSES FOR MAKING DIALKYL ETHERS FROM ALCOHOLS | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 2010-08-05 | — | — | US | claimed |
| US-20100174120-A1 | PROCESSES FOR MAKING DIBUTYL ETHERS FROM ISOBUTANOL | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 2010-07-08 | — | — | US | claimed |
| US-20090292126-A1 | Ionic Liquids | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2009-11-26 | — | — | US | claimed |
| EP-1940914-B1 | PREPARATION OF POLYTRIMETHYLENE ETHER GLYCOL AND COPOLYMERS THEREOF | DU PONT (US) | 2009-05-13 | — | — | EP | claimed |
| US-7528287-B2 | Preparation of poly(tetramethylene) glycol | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 2009-05-05 | — | — | US | claimed |
| US-20080221241-A1 | Flame Retardant Polycarbonate Compositions | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2008-09-11 | — | — | US | claimed |
| US-7238772-B2 | Preparation of polytrimethylene ether glycol and copolymers thereof | E. I. DU PONT DE NEMOURS AND COMPANY (DE) | 2007-07-03 | — | — | US | claimed |
| US-20070100181-A1 | Olefin isomerization | E. I. DU PONT DE NEMOURS AND COMPANY | 2007-05-03 | — | — | US | claimed |
| US-20070100184-A1 | Alkylation of aromatic compounds | E. I. DU PONT DE NEMOURS AND COMPANY | 2007-05-03 | — | — | US | claimed |
| US-20070066852-A1 | Preparation of poly(tetramethylene) glycol | THE CHEMOURS COMPANY FC, LLC | 2007-03-22 | — | — | US | claimed |
| US-20070066854-A1 | Preparation of polytrimethylene ether glycol and copolymers thereof | THE CHEMOURS COMPANY FC, LLC | 2007-03-22 | — | — | US | claimed |
| US-20070066822-A1 | Ionic liquids | THE CHEMOURS COMPANY FC, LLC | 2007-03-22 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (9 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100174120-A1 | PROCESSES FOR MAKING DIBUTYL ETHERS FROM ISOBUTANOL | EBP, PPIP5K2, PCBP1 | DNM1 3200/4885KCNH2 1554/4885EPHX1 1232/4885 |
| US-20100197974-A1 | PROCESSES FOR MAKING DIALKYL ETHERS FROM ALCOHOLS | ADH1C, DCLK1, GK | DNM1 3892/4885KCNH2 325/4885EPHX1 2570/4885 |
| US-20070100184-A1 | Alkylation of aromatic compounds | TYR, ALK, AHR | DNM1 3341/4885KCNH2 1186/4885EPHX1 3543/4885 |
| US-20070066854-A1 | Preparation of polytrimethylene ether glycol and copolymers thereof | PARG, PTGES3, PGD | DNM1 2154/4885KCNH2 2378/4885EPHX1 1238/4885 |
| US-20100204521-A1 | PROCESSES FOR MAKING DIBUTYL ETHERS FROM 2-BUTANOL | TRIB2, EBP, DAB2IP | DNM1 3462/4885KCNH2 1685/4885EPHX1 921/4885 |
| US-20070100181-A1 | Olefin isomerization | OSBP, OXER1, ALOX12 | DNM1 607/4885KCNH2 2857/4885EPHX1 568/4885 |
| US-20070066822-A1 | Ionic liquids | AFF2, AFF1, ZYX | DNM1 3860/4885KCNH2 273/4885EPHX1 4749/4885 |
| US-20090292126-A1 | Ionic Liquids | INF2, MOGAT2, FLI1 | DNM1 1694/4885KCNH2 1220/4885EPHX1 857/4885 |
| US-20070066852-A1 | Preparation of poly(tetramethylene) glycol | PARG, PUF60, TPR | DNM1 1732/4885KCNH2 860/4885EPHX1 3566/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.